ciprofloxacin has been researched along with ly 163892 in 11 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 3 (27.27) | 18.2507 |
2000's | 2 (18.18) | 29.6817 |
2010's | 6 (54.55) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
Miller, MJ; Möllmann, U; Nora, GP | 1 |
Campillo, NE; Guerra, A; Páez, JA | 1 |
Annand, R; Gozalbes, R; Jacewicz, M; Pineda-Lucena, A; Tsaioun, K | 1 |
Miller, MJ; Wencewicz, TA | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Cheng, W; Kong, H; Wei, H; Yang, Z; Yuan, Y; Zhang, X | 1 |
Belcher, J; Cole, PJ; Kanthakumar, K; Lund, V; Read, RC; Roberts, DE; Rutman, A; Tsang, KW; Wilson, R | 1 |
Preston, DA; Turik, M | 1 |
Blondeau, JM; Borsos, S; Suter, M | 1 |
Cattrall, JWS; Kirby, A; Robinson, AV | 1 |
2 review(s) available for ciprofloxacin and ly 163892
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
A systematic review of randomised clinical trials for oral antibiotic treatment of acute pyelonephritis.
Topics: Acute Disease; Administration, Oral; Anti-Bacterial Agents; Cephalosporins; Ciprofloxacin; Drug Combinations; Humans; Norfloxacin; Pyelonephritis; Randomized Controlled Trials as Topic; Sulfamethizole; Trimethoprim | 2018 |
9 other study(ies) available for ciprofloxacin and ly 163892
Article | Year |
---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
The synthesis and in vitro testing of structurally novel antibiotics derived from acylnitroso Diels-Alder adducts.
Topics: Anti-Bacterial Agents; Escherichia coli; Microbial Sensitivity Tests; Molecular Structure | 2006 |
Neural computational prediction of oral drug absorption based on CODES 2D descriptors.
Topics: Administration, Oral; Humans; Models, Chemical; Neural Networks, Computer; Permeability; Quantitative Structure-Activity Relationship; Technology, Pharmaceutical | 2010 |
QSAR-based permeability model for drug-like compounds.
Topics: Caco-2 Cells; Cell Membrane Permeability; Drug Discovery; Humans; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2011 |
Biscatecholate-monohydroxamate mixed ligand siderophore-carbacephalosporin conjugates are selective sideromycin antibiotics that target Acinetobacter baumannii.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Agar; Anti-Bacterial Agents; Cephalosporins; Culture Media; Ferrous Compounds; Indicators and Reagents; Iron; Microbial Sensitivity Tests; Peptides; Topoisomerase II Inhibitors | 2013 |
An overview of recent progress in siderophore-antibiotic conjugates.
Topics: Anti-Bacterial Agents; Dose-Response Relationship, Drug; Gram-Negative Bacteria; Humans; Microbial Sensitivity Tests; Molecular Structure; Siderophores; Structure-Activity Relationship | 2019 |
Haemophilus influenzae infection of human respiratory mucosa in low concentrations of antibiotics.
Topics: Adenoids; Amoxicillin; Anti-Bacterial Agents; Cephalosporins; Child, Preschool; Ciprofloxacin; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Haemophilus Infections; Haemophilus influenzae; Humans; Microbial Sensitivity Tests; Microscopy, Electron; Mucociliary Clearance; Mucous Membrane; Organ Culture Techniques; Respiratory Tract Infections | 1993 |
Cefaclor: a contemporary look at susceptibility of key pathogens from around the globe.
Topics: Anti-Infective Agents; Cefaclor; Cephalosporins; Ciprofloxacin; Escherichia coli; Haemophilus influenzae; Methicillin Resistance; Microbial Sensitivity Tests; Moraxella catarrhalis; Penicillin Resistance; Staphylococcus aureus | 1998 |
Determination of the antimicrobial susceptibilities of Canadian isolates of Haemophilus influenzae, Streptococcus pneumoniae and Moraxella catarrhalis. Canadian Antimicrobial Study Group.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Cephalosporins; Ciprofloxacin; Haemophilus influenzae; Microbial Sensitivity Tests; Moraxella catarrhalis; Penicillin Resistance; Respiratory Tract Infections; Streptococcus pneumoniae | 1999 |